Butamirate
- Level
- Commodity
- Parent
- 51162600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51162611This classification denotes an antitussive agent with the molecular formula C18H29NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) M75MZG2236, chemically known as butyric acid, 2-phenyl-, 2-(2-(diethylamino)ethoxy)ethyl ester, citrate but more generally known as butamirate, which bears US NIH Compound Identifier 28891. Butamirate most often comes in base and citrate forms. European Medicines Agency schedules Butamirate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06000MIG. The term BUTAMIRATE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules butamirate in its Anatomical Therapeutic Chemical (ATC) Classification. BUTAMIRATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule butamirate under HS 29221980 and SITC 51461. As of Q4 2014, BUTAMIRATE remains US FDA's Preferred Term for this commodity. Butamirate bears US NLM identifiers UMLS ID C0054236 and NCI Concept Code C81596. SMILES: O(CCN(CC)CC)CCOC(=O)C(CC)C1CCCCC1.OC(CC(=O)O)(CC(=O)O)C(=O)O.
Same parent
Under 51162600 · 55Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.